| EP1684370A4 (en) | | Electrode active material and use thereof |
| GB0206876D0 (en) | | Therapeutic agents |
| GB0209991D0 (en) | | Therapeutic agents |
| GB0209995D0 (en) | | Therapeutic agents |
| EP1620120A4 (en) | | Long acting biologically active conjugates |
| AU2003213997A1 (en) | | Biologically active copper-organic agents |
| GB0205347D0 (en) | | Biologically active complex |
| AU2003295107A8 (en) | | Biological control agent and formulations |
| GB2411404B (en) | | Biologically active peptide conjugates |
| AU2003224316A8 (en) | | Device for delivery of biologically active agents |
| GB0229126D0 (en) | | Biological control agent and formulations |
| AU2002343197A8 (en) | | Biologically active complex |
| AU6269901A (en) | | Biologically active agents and drugs |
| AU2001262699A1 (en) | | Biologically active agents and drugs |
| GB0306345D0 (en) | | Biologically and therapeutically active agents |
| GB0305644D0 (en) | | Biologically and therapeutically active agents |
| GB0219029D0 (en) | | Biologically and therapeutically active agents |
| GB0219031D0 (en) | | Biologically and therapeutically active agents |
| GB0411432D0 (en) | | Biologically and therapeutically active agents |
| GB0208394D0 (en) | | Therapeutic agents |
| GB0304549D0 (en) | | Biologically and therapeutically active agents against HIV-1 |
| GB0103354D0 (en) | | Biologically active agents |
| GB0119981D0 (en) | | Biologically and therapeutically active agents |
| GB0119264D0 (en) | | Biologically and therapeutically active agents |
| GB0218483D0 (en) | | Biologically and therapeutically active agents against HIV-1 |